Products & ReviewLife Sciences
SAHA
Epigenetic modifier; Inhibits HDAC1 and HDAC3
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
SAHA (suberoylanilide hydroxamic acid) is a potent inhibitor of class I and class II histone deacetylases (HDACs). This compound inhibits the activities of HDAC1 and HDAC3 (IC50 = 10 nM and 20 nM, respectively; Richon et al.). SAHA exhibits antiproliferative properties and can cause cell cycle arrest at G1 (Marks & Breslow).
REPROGRAMMING
- Improves reprogramming efficiency from human and mouse somatic to induced pluripotent stem cells (Huangfu et al.).
CANCER RESEARCH
- Downregulates homologous recombination and leads to apoptosis in ovarian cancer cells when used in combination with olaparib (Konstantinopoulos et al.).
- SAHA downregulates Nanog expression, which leads to proliferation inhibition in head and neck cancer stem cells (Kumar et al.).